Unknown

Dataset Information

0

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.


ABSTRACT:

Background

Vasohibin-2 (VASH2) has been identified as an endogenous and vascular endothelial growth factor (VEGF)-independent angiogenic factor that is highly expressed in tumor cells. In the present study, we aimed to determine whether pre-existing vascular changes can be used to predict tumor transformation as benign or malignant. We sought to characterize microvascular changes and tumor development in the intestinal tract of ApcMin/+ mice and ApcMin/+/Vash2-/- mice.

Methods

ApcMin/+ mice provide a unique orthotopic model for the development of spontaneous adenomatous polyposis and subsequent carcinomas, a phenomenon termed the adenoma-carcinoma sequence. ApcMin/+ mice were mated with Vash2-/- mice with a mixed C57BL/6 background and the resulting pups were screened for the Min mutation and for the Vash2-/- gene by PCR. Intestinal tumors from ApcMin/+ mice and ApcMin/+/Vash2-/- mice were removed and either frozen or epon-embedded for subsequent analyses. For 3-dimensional imaging using confocal laser-scanning microscopy and transmission electron microscopy, cryosections were made, and immunofluorescent staining for various markers was performed.

Results

We found that structural abnormalities in tumor vessels from benign tumors resembled those in malignant tumors. In addition, a novel angiogenic factor, vasohibin-2 (VASH2) protein, was detected around tumor blood vessels in late-stage adenomas and adenocarcinomas, but was absent from early-stage adenomas in ApcMin/+ mice. Tumors used to examine endogenous VASH2 (derived from CMT93 colon carcinomas) were less vascularized in Vash2-/- mice and were more regular than those seen in wild-type (WT) mice. In addition, tumors in Vash2-/- mice were smaller than those in WT mice. Furthermore, cross-breeding of mice homozygous for a deletion of Vash2 with mice heterozygous for the APC mutation resulted in animals that showed a significant decrease in the number of polyps in the small intestine.

Conclusion

We propose that VASH2 may modulate the onset of tumors in the gastrointestinal tract by regulating tumor angiogenesis.

SUBMITTER: Kitahara S 

PROVIDER: S-EPMC4113181 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.

Kitahara Shuji S   Suzuki Yasuhiro Y   Morishima Masae M   Yoshii Asuka A   Kikuta Sachiko S   Shimizu Kazuhiko K   Morikawa Shunichi S   Sato Yasufumi Y   Ezaki Taichi T  

Molecular cancer 20140504


<h4>Background</h4>Vasohibin-2 (VASH2) has been identified as an endogenous and vascular endothelial growth factor (VEGF)-independent angiogenic factor that is highly expressed in tumor cells. In the present study, we aimed to determine whether pre-existing vascular changes can be used to predict tumor transformation as benign or malignant. We sought to characterize microvascular changes and tumor development in the intestinal tract of ApcMin/+ mice and ApcMin/+/Vash2-/- mice.<h4>Methods</h4>Apc  ...[more]

Similar Datasets

| S-EPMC518662 | biostudies-literature
| S-EPMC8199308 | biostudies-literature
| S-EPMC7761520 | biostudies-literature
2012-09-13 | E-GEOD-34292 | biostudies-arrayexpress
| S-EPMC4956776 | biostudies-literature
2024-03-20 | PXD044789 | Pride
2012-09-13 | GSE34292 | GEO
| S-EPMC5439111 | biostudies-literature
2016-10-06 | PXD003805 | Pride
| S-EPMC9870894 | biostudies-literature